Common questions about Scabisan (FAQ)
Q: Is Scabisan the same as permethrin?
A: Scabisan is a brand name for a topical medicine. According to official product labeling, its single active ingredient is permethrin. Permethrin is the specific chemical compound that carries out the drug’s primary action against external parasites.
Q: Is Scabisan an antibiotic?
A: No, Scabisan is not an antibiotic. Official sources classify the medicine as an ectoparasiticide and scabicidal agent because it is designed specifically to eliminate parasites like mites and lice. It is not indicated for treating bacterial infections.
Q: How quickly does Scabisan start working after application?
A: Permethrin, the active ingredient, works by causing the rapid paralysis of the target parasites by disrupting their nerve function. Outcomes are generally assessed in clinical studies at follow-up points, typically between 7 and 14 days after the single application, to check for signs of persistent pests.
Q: Are there any common over-the-counter creams that interact with Scabisan?
A: Official documentation specifically instructs that topical corticosteroids should be withheld immediately prior to Scabisan application. However, there are no other specific common over-the-counter creams listed as having documented systemic interactions.
Q: What happens if you accidentally get Scabisan in your eye?
A: Regulatory guidance advises avoiding contact with the eyes during the application process. If accidental eye contamination occurs, regulatory guidance advises that the affected area should be rinsed immediately with plenty of water or, if available, normal saline solution.
Q: What is the guidance for using Scabisan while breastfeeding?
A: Regulatory labeling advises caution because it is not known whether the substance passes into human milk. Official guidance suggests that consideration should be given to discontinuing nursing temporarily or withholding the drug while the mother is breastfeeding.
Q: Are there different strengths of Scabisan available?
A: Yes, the active ingredient permethrin is described in regulatory documents in different strengths depending on its approved use. These include a 5% cream typically used for scabies and a 1% liquid or lotion for treating head lice.
Q: Why do official documents mention not using Scabisan on broken skin?
A: Official warnings state that the cream should not be applied to areas of broken skin, mucous membranes, or open wounds. This restriction is in place because the product itself may cause marked irritation if applied to these sensitive or compromised areas.
Q: Is Scabisan only for use on the body, or can it be used on the scalp?
A: The area of application is defined by the specific formulation and the patient’s age. While the 5% cream usually spares the head/scalp in adults, regulatory documents advise that for infants (2 months and older) and geriatric patients, the application must include the scalp, face, ears, and neck.
Q: What is the official guidance if a dose of Scabisan is missed?
A: Official administration guidelines define Scabisan as a time-bound single-application course, meaning there is no conventional guidance for a 'missed dose.' Reapplication is only considered if follow-up assessment finds evidence of persistent live pests after a regulated waiting period, typically 7 to 14 days.
Q: Does Scabisan interact with petroleum jelly or mineral oil?
A: Official documents do not list specific warnings against using these products alongside Scabisan. However, some permethrin formulations themselves may contain mineral oil as an inactive ingredient, indicating an expected compatibility with related substances.
Q: Can Scabisan cause a skin reaction that looks like a rash?
A: Yes. According to regulatory labeling, skin reactions like erythema (redness) and rash have been reported as adverse reactions. These effects are often localized and may appear at the beginning of treatment.
Q: Can people with a history of eczema use Scabisan?
A: Official documents note that individuals with a history of eczema may experience a temporary exacerbation (worsening) of their condition upon application. The official guidance also notes that treatment of eczematous-like reactions with topical corticosteroids should be withheld prior to using Scabisan.
Q: Are there any official warnings about sun exposure while using Scabisan?
A: Regulatory documents do not contain specific warnings about photosensitivity or sun exposure related to the drug itself. The official warnings are primarily focused on avoiding contact with sensitive areas and proper application procedures.
Q: Can Scabisan be used for prevention, or is it only for active conditions?
A: The official indication for the 5% cream is strictly for the treatment of infestation with the Sarcoptes scabiei mite (scabies). Prevention, or prophylactic use, is not listed as an approved use in the prescribing information.
Q: Why do official sources state to avoid alcohol near the time of application?
A: The product's regulatory label states that interactions with food, alcohol, or herbal products are not established or documented due to minimal absorption into the bloodstream. Therefore, official documents state that interactions with alcohol are not established or documented in the product labeling.
Q: Can applying too much Scabisan cause more side effects?
A: Official documentation advises against excessive application, noting that it might result in localized adverse reactions or more severe skin reactions. These can include increased irritation and redness at the site of application.
Q: What constitutes a severe reaction to Scabisan that requires attention?
A: Official documentation classifies severe hypersensitivity reactions (allergic reactions) and angioedema as rare but serious adverse reactions. Signs of these may include swelling of the face, lips, tongue, or throat, the appearance of hives, or difficulty breathing.
Q: Is it true that Scabisan might not kill eggs, only the adult parasites?
A: The research record for permethrin has explored its potential for ovicidal activity (killing eggs), especially in the context of lice treatment. The overall outcome of a single application is often assessed by monitoring for signs of persistent live pests or eggs after the treatment interval.
Q: Does Scabisan interact with herbal supplements?
A: Official regulatory documents establish that interactions with herbal products or supplements are not established or documented. This is primarily attributed to the drug's limited systemic absorption into the bloodstream when applied topically.
Q: Is it important to wash clothes and bedding after using Scabisan?
A: Regulatory guidance often describes steps to decontaminate items like clothes, bedding, and towels that were in contact with the affected person. This may involve washing them in very hot water or dry cleaning, or sealing them in an airtight plastic bag for a defined period to eliminate any remaining pests.
Q: Does Scabisan treat more than just one type of skin condition?
A: Scabisan is an ectoparasiticide indicated for treating specific parasitic infestations, namely scabies (caused by mites) and pediculosis (caused by lice). It is not indicated for general inflammatory skin conditions, fungal, or bacterial infections.
Q: Are there specific parts of the body that should not have Scabisan applied?
A: Yes. Official documentation advises against applying the product to mucous membranes (like the inside of the nose, mouth, or genital area) and near the eyes. The product can cause marked irritation if it comes into contact with these sensitive areas.
